TOFA 10 mg | Purity Not Available
StressMarq Biosciences
TOFA
Search Results
(±)-CP 47,497-C8-homolog 5mg | 98%
APEXBIO TECHNOLOGY LLC
(±)-CP 47,497-C8-homolog
(±)-CP 47,497-C8-homolog 10mg | 98%
APEXBIO TECHNOLOGY LLC
(±)-CP 47,497-C8-homolog
(±)-CP 47,497-C8-homolog 25mg | 98%
APEXBIO TECHNOLOGY LLC
(±)-CP 47,497-C8-homolog
(±)-CP 55,940 10mg | ≥95%
Musechem
(±)-CPP inquiry | Purity Not Available
Alfa Chemistry
(±)-CPSI 1306 Please inquire | ≥98%
BOC Sciences
(±)-CPSI 1306 has been found to be a MIF inhibitor and could also be used in the synthesis of some isoxazolines compounds.
More Information Supplier Page(±)-CPSI 1306 10mg | 98%
APEXBIO TECHNOLOGY LLC
(±)-CPSI 1306
(±)-CPSI-1306 1 mL | 97.98%
TargetMol
(±)-CPSI-1306 is a macrophage migration inhibitory factor (MIF) antagonist and can be used in studies about non-insulin-dependent diabetes mellitus (NIDDM) and the prevention of the deleterious cutaneous effects of acute and chronic UVB exposure.
More Information Supplier Page(±)-CPSI-1306
(±)-CPSI-1306 10 mg | 97.98%
TargetMol
(±)-CPSI-1306 is a macrophage migration inhibitory factor (MIF) antagonist and can be used in studies about non-insulin-dependent diabetes mellitus (NIDDM) and the prevention of the deleterious cutaneous effects of acute and chronic UVB exposure.
More Information Supplier Page(±)-CPSI-1306
(±)-CPSI-1306 25 mg | 97.98%
TargetMol
(±)-CPSI-1306 is a macrophage migration inhibitory factor (MIF) antagonist and can be used in studies about non-insulin-dependent diabetes mellitus (NIDDM) and the prevention of the deleterious cutaneous effects of acute and chronic UVB exposure.
More Information Supplier Page(±)-CPSI-1306